'''Fludiazepam''', marketed under the brand name '''Erispan''' ('''エリスパン''')<ref>{{Cite journal | last1 = Su | first1 = TP. | last2 = Chen | first2 = TJ. | last3 = Hwang | first3 = SJ. | last4 = Chou | first4 = LF. | last5 = Fan | first5 = AP. | last6 = Chen | first6 = YC. | title = Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000. | journal = Zhonghua Yi Xue Za Zhi (Taipei) | volume = 65 | issue = 8 | pages = 378–91 |date=Aug 2002 | PMID = 12455808 }}</ref><ref>{{cite web|url=http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html |title=Benzodiazepine Names |accessdate=2008-12-29 |publisher=non-benzodiazepines.org.uk |deadurl=yes |archiveurl=https://web.archive.org/web/20081208054743/http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html |archivedate=2008-12-08 |df= }}</ref> is a potent [[benzodiazepine]] and 2ʹ-fluoro derivative of [[diazepam]],<ref>{{Cite journal | last1 = Neville | first1 = GA. | last2 = Beckstead | first2 = HD. | last3 = Shurvell | first3 = HF. | title = A Fourier transform-Raman and infrared vibrational study of delorazepam, fludiazepam, flurazepam, and tetrazepam. | journal = J Pharm Sci | volume = 83 | issue = 2 | pages = 143–51 |date=Feb 1994 | PMID = 7909552 | doi=10.1002/jps.2600830207}}</ref> originally developed by [[Hoffman-La Roche]] in the 1960s.<ref>US Patent 3299053 -ARYL-JH-L,X-BENZODIAZEPIN-Z(LH)-ONES</ref> It is marketed in [[Japan]] and [[Taiwan]]. {{cn|date=March 2016}} It exerts its pharmacological properties via enhancement of GABAergic inhibition.<ref>{{Cite journal | last1 = Tsuchiya | first1 = T. | last2 = Fukushima | first2 = H. | title = Effects of benzodiazepines and pentobarbitone on the gaba-ergic recurrent inhibition of hippocampal neurons. | journal = Eur J Pharmacol | volume = 48 | issue = 4 | pages = 421–4 |date=Apr 1978 | PMID = 648585 | doi=10.1016/0014-2999(78)90169-3}}</ref> Fludiazepam has 4 times more binding affinity for [[GABAA receptor|benzodiazepine receptors]] than [[diazepam]].<ref>{{Cite journal | last1 = Nakatsuka | first1 = I. | last2 = Shimizu | first2 = H. | last3 = Asami | first3 = Y. | last4 = Katoh | first4 = T. | last5 = Hirose | first5 = A. | last6 = Yoshitake | first6 = A. | title = Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity. | journal = Life Sci | volume = 36 | issue = 2 | pages = 113–9 |date=Jan 1985 | pmid = 2857046 | doi=10.1016/0024-3205(85)90089-X}}</ref> It possesses [[anxiolytic]],<ref>{{Cite journal | last1 = Okada | first1 = S. | last2 = Ichiki | first2 = K. | last3 = Tanokuchi | first3 = S. | last4 = Ishii | first4 = K. | last5 = Hamada | first5 = H. | last6 = Ota | first6 = Z. | title = Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus. | journal = J Int Med Res | volume = 22 | issue = 6 | pages = 338–42 | PMID = 7895897 | year=1994}}</ref><ref>{{Cite journal | last1 = Okada | first1 = S. | last2 = Ichiki | first2 = K. | last3 = Tanokuchi | first3 = S. | last4 = Ishii | first4 = K. | last5 = Hamada | first5 = H. | last6 = Ota | first6 = Z. | title = Improvement of stress reduces glycosylated haemoglobin levels in patients with type 2 diabetes. | journal = J Int Med Res | volume = 23 | issue = 2 | pages = 119–22 | PMID = 7601294 | year=1995}}</ref><ref>{{Cite journal | last1 = Okada | first1 = S. | last2 = Ichiki | first2 = K. | last3 = Tanokuchi | first3 = S. | last4 = Ishii | first4 = K. | last5 = Hamada | first5 = H. | last6 = Ota | first6 = Z. | title = How blood pressure in patients with non-insulin-dependent diabetes mellitus is influenced by stress. | journal = J Int Med Res | volume = 23 | issue = 5 | pages = 377–80 | PMID = 8529781 | year=1995}}</ref> [[anticonvulsant]], [[sedative]], [[hypnotic]] and [[skeletal muscle relaxant]] properties.<ref>{{Cite journal | last1 = Inoue | first1 = H. | last2 = Maeno | first2 = Y. | last3 = Iwasa | first3 = M. | last4 = Matoba | first4 = R. | last5 = Nagao | first5 = M. | title = Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. | journal = Forensic Sci Int | volume = 113 | issue = 1-3 | pages = 367–73 |date=Sep 2000 | pmid = 10978650 | doi=10.1016/S0379-0738(00)00226-7}}</ref>
